Navigation Links
Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
Date:9/16/2013

nsing Agreement with Takeda Pharma 686.1.3 Palatin Technologies Extends License Agreement with AstraZeneca 696.1.4 Zealand Pharma Enters into Licensing and Collaboration Agreement with Boehringer Ingelheim 696.2 Co-development Deals 706.2.1 Isis Enters into Collaboration Agreement with Ortho-McNeil 716.2.2 Orexigen Therapeutics Enters into Co-development Agreement with Takeda Pharma for Contrave 717 Appendix 727.1 References 727.2 Abbreviations 767.3 All Pipeline Drugs by Phase 797.3.1 Discovery 797.3.2 Preclinical 807.3.3 Phase I 847.3.4 Phase II 857.3.5 Phase III 867.3.6 Pre-Registration 867.4 Market Forecasts to 2019 877.4.1 Global 877.4.2 The US 877.4.3 UK 887.4.4 France 887.4.5 Germany 887.4.6 Italy 897.4.7 Spain 897.4.8 Japan 897.5 Methodology 907.6 Secondary Research 907.7 Therapeutic Landscape 907.8 Epidemiology-Based Forecasting 917.9 Market Size by Geography 927.10 Pipeline Analysis 937.11 Contact Us 937.12 Disclaimer 93

1.1 List of Tables

Table 1: BMI Classifications 10Table 2: Key Components of Pathways Thought to be Related to Obesity 14Table 3: Treatment Options Dependent on BMI 16Table 4: Obesity Therapeutics, Leading Brand Names of Phentermine 18Table 5: Efficacy Results* for Qsymia at 52 Weeks 21Table 6: Changes in Key Safety Parameters in Patients Treated with Qsymia 21Table 7: Sales Data for Xenical ($m), 2008–2011 23Table 8: Efficacy Results for Orlistat as an Initial and Maintenance Therapy 24Table 9: Safety Results of Orlistat 25Table 10: Efficacy Results for Belviq 27Table 11: Placebo-adjusted Safety Results for Belviq 27Table 12: Obesity Therapeutics Market, Global, Common Molecular Targets in the Obesity Pipeline 35Table 13: Obesity Therapeutics Market, Global, Average Clinical Trial Size for the Most Common Modes of Action Amongst Pipeline Drugs, 2006–2013 3
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Childhood Obesity Need Not Last a Lifetime, says Beverly Hills Physicians
2. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
3. seca Supports Obesity Therapy with the New medical Body Composition Analyzer
4. Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
5. The Financial Impact of Obesity in Brazil and Mexicos Healthcare Systems is Driving Partial Coverage of Obesity Drugs in Formularies at the State, Municipal and Hospital Levels
6. NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity
7. Link Between Cancer and Obesity Argues for More Aggressive Treatments, says Dr. Feiz & Associates
8. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
9. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
10. Analysis In Health Economics Review Concludes Effective Medical Obesity Treatment Could Reduce Medicare Spending
11. Americas Interest in Obesity Surgery Soars Following its Success in Europe and ROW, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... MARLBOROUGH, Mass , Dec. 22, 2014 /PRNewswire/ -- ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today issued the following open ... Geert Cauwenbergh , Dr. Med. Sc. ... few days a number of inaccurate statements posted ...
(Date:12/22/2014)... 22, 2014  Eiger BioPharmaceuticals Incorporated announced the ... lonafarnib in patients with chronic hepatitis delta virus ... National Institutes of Health (NIH) Clinical Center in ... randomized, placebo-controlled, dose ascending study evaluated two doses ... mg twice daily for 28 days.  "This proof-of-concept ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, announced today ... dosed in a pharmacokinetic and pharmacodynamic study with ... neuropathic pain. Racemic methadone is a ... pain states and substitution therapy in opioid addiction.  ...
Breaking Medicine Technology:RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3
... in the high dose groups achieved disease stabilization. ... ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), ... from its Phase 2 monotherapy clinical study of ... patients. In this monotherapy study 66% of patients ...
... STOCKHOLM, March 4 Diamyd Medical announces,today that the ... the,Diamyd(R) diabetes vaccine in children with high risk to ... http://www.newscom.com/cgi-bin/prnh/20080314/297194 ) , ... been one of,Diamyd Medical,s long term goals," says Elisabeth ...
Cached Medicine Technology:Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 2Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 3Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results 4Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved 2
(Date:12/22/2014)... Only weeks following the announcement that Henderson, Nevada ... a battery manufacturer create 29 well-paying jobs in Mojave ... launching in Henderson to deliver yet another win ... sector is going to build a stronger middle class ... works with small businesses that rely on middle class ...
(Date:12/22/2014)... December 22, 2014 In recognition of ... sales to Hero Reward, a local organization that provides ... , Located on a couple hundred acres ... Program offers lodging, world class fishing, hunting, hiking, horseback ... was founded several years ago to support U.S. Service ...
(Date:12/22/2014)... Pasadena sleep apnea dentist, ... apnea. Drowsy drivers are 15 times more likely to ... and some experts believe that sleep-deprived drivers may be ... Unfortunately, millions of Americans may be sleep-deprived without even ... Medicine, about 18 million Americans have sleep apnea, but ...
(Date:12/22/2014)... Texas (PRWEB) December 22, 2014 7,178 ... and bustle of Black Friday shopping and opted instead ... and marketing education company, for their 5th annual “Black ... charged just $7 to attend the 5 hour ... that they promptly donated to support two Central Texas ...
(Date:12/22/2014)... Luxury Linen purveyor Peacock Alley once again ... provide logistics and support for one of Dallas’ largest holiday ... history of giving back to the community in which it ... Drive were Whataburger® and 99.5 The Wolf. , There is ... gifts to children who would otherwise not receive any is ...
Breaking Medicine News(10 mins):Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Pasadena Dentist, Dr. Marine Martirosyan, Now Offers Consultations for Sleep Apnea 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2
... VPP "STAR" DesignationBROOKS, Ore., April 15 Covanta ... (NYSE: CVA ) and a world ... scale Energy-from-Waste and other renewable energy projects, today ... status in the Oregon Department of Consumer and ...
... 15 A new series of national public service ... their health care by knowing and asking appropriate questions ... today by the U.S. Department of Health and Human ... Advertising Council and actress and health advocate Fran Drescher.The ...
... insomnia as a way to address pain, , , WEDNESDAY, April ... people with cancer has often led to trouble sleeping -- ... in fact, sleep seems to cause those problems rather than ... interventions such as cognitive behavioral therapy aimed at eliminating the ...
... The following is a statement by Joseph A. ... Addiction and Substance Abuse at Columbia University :Congratulations ... Carpenter-Palumbo, Commissioner of the New York State Office of ... Collaborative to Improve Outcomes for New York (ACTION) initiative ...
... NEW YORK, April 15 The impetus for the ... settlement by Quest Diagnostics Inc. was a "qui tam" ... the government revealed today. The qui tam lawsuit provided ... a Quest subsidiary, Nichols Institute Diagnostics Inc. (NID), manufactured ...
... go "Meatless" on MondaysNEW YORK, April 15 With World ... environmental advocates are calling on President Obama to take a ... of his predecessors in office have done. Watch the Meatless ... Roosevelt all instituted national meatless days in order to divert ...
Cached Medicine News:Health News:Covanta Marion Recognized for Health and Safety by Oregon OSHA 2Health News:Covanta Marion Recognized for Health and Safety by Oregon OSHA 3Health News:AHRQ and Ad Council Encourage Consumers to Ask Questions and Get More Involved in Their Health Care 2Health News:AHRQ and Ad Council Encourage Consumers to Ask Questions and Get More Involved in Their Health Care 3Health News:Businessman Exposed Problems With Quest Subsidiary's Blood Test Kits; Led to $302 Million Settlement 2Health News:Businessman Exposed Problems With Quest Subsidiary's Blood Test Kits; Led to $302 Million Settlement 3Health News:Obama Urged to Bring Back National Meatless Program 2
... The XL Advantage delivers higher magnification for ... crisp, true image, even at the highest ... edge clarity and precise color rendition is ... with an anti-reflective coating produce a superior ...
... delivers higher magnification for advanced surgical procedures. ... even at the highest magnification. 3.5x, 4.5x ... precise color rendition is ideal for surgical ... coating produce a superior image. The compact ...
... Advantage delivers higher magnification for advanced surgical ... image, even at the highest magnification. 3.5x, ... and precise color rendition is ideal for ... anti-reflective coating produce a superior image. The ...
... Prismatic loupes are higher ... guarenteeing edge to edge ... rendition., ,Keeler Prismatic loupes ... treated with anti reflective ...
Medicine Products: